[Risk with strict glucose control and hydroxyethyl starch in severe sepsis. Routine intensive care treatments are now questioned].
Berggren
Lars
L
Intensivvårdsavdelningen, Universitetssjukhuset, Orebro. lars.berggren@orebroll.se
D058186:Acute Kidney Injury / Q000209:etiology; D001786:Blood Glucose / Q000032:analysis*; D003422:Critical Care / Q000379:methods*; D016638:Critical Illness; D005440:Fluid Therapy / Q000379:methods; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage* / Q000009:adverse effects; D007003:Hypoglycemia / Q000139:chemically induced; D007328:Insulin / Q000008:administration & dosage; D010952:Plasma Substitutes / Q000008:administration & dosage* / Q000009:adverse effects; D012307:Risk Factors; D018805:Sepsis / Q000401:mortality / Q000628:therapy*
D001786:Blood Glucose; D006895:Hydroxyethyl Starch Derivatives; D007328:Insulin; D010952:Plasma Substitutes